CRAIG PATTON: Open Payments
NPI 1750008728 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 96 payments from 14 companies in 2025. Trend: 2023 $970 · 2024 $1,118 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $326 |
| ABBVIE INC. | 30 | $252 |
| Supernus Pharmaceuticals, Inc. | 4 | $82 |
| Janssen Pharmaceuticals, Inc | 4 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Tris Pharma Inc | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, Qelbree, Jornay PM, SPRAVATO, COBENFY, ABILIFY MAINTENA, REXULTI.
Industry payments across OK — which companies pay providers there.
